KARA ANOSKEY: Open Payments
NPI 1235732256 · WESTFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 13 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| Inari Medical, Inc. | 1 | $73 |
| Amgen Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Corium, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: FLOWTRIEVER CATHETER, S, XIFAXAN, Auvelity, TRELEGY ELLIPTA, UBRELVY, OTEZLA, REPATHA, Azstarys.
Industry payments across IN — which companies pay providers there.
